FOR IMMEDIATE RELEASE
Medidata Solutions Executive Earl Hulihan Honored with
DIA Founders Service Award
DIA Board of Directors to Recognize Medidata’s Vice President of
Global Regulatory Affairs and Quality Assurance at Annual Meeting
NEW YORK, NY – June 11, 2007 – Medidata Solutions, a global leader in electronic data capture (EDC), management and reporting solutions, today announced that Vice President of Global Regulatory Affairs and Quality Assurance Earl Hulihan has been selected to receive the Drug Information Association’s (DIA) Founders Service Award. This award recognizes individuals who have advanced the mission, vision and values of DIA and fostered the growth and development of the organization through their sustained dedication, time and effort.
DIA’s highest honor for volunteerism, the Founders Service Award honors Hulihan’s lifelong contributions to medicine, regulatory science and people around the world throughout his distinguished career. Hulihan has helped the industry make significant strides in quality assurance, regulatory compliance, drug development and clinical research since the early 1970s. As the current Vice President of Global Regulatory Affairs and Quality Assurance at Medidata Solutions, Hulihan is responsible for maintaining the highest standards for all Medidata products and services, and ensuring compliance with the US and international clinical and quality regulations.
Outside of the professional environment, Hulihan has provided advice and training to regulatory agency personnel within the U.S. FDA, European and Asian communities and has more than 15 years of experience in clinical medicine as a research specialist, teaching specialist, clinical physiologist and clinical investigator. Hulihan has been involved with DIA for over 30 years and is a frequent contributor to seminars, training and events and serves as global chair of the Validation SIAC/Community and vice-chair of the DIA Advisory Council for North America. He has been very active in the most recent launch of DIA initiatives within the India and China regions.
“DIA has always been one of the most influential associations and driving forces in the industry, and I am honored to have been able to contribute to the organization over the years,” said Hulihan. “Medidata Solutions consistently maintains a strong presence at DIA conferences and events, and I look forward to continuing to drive critical discussions and foster commitment to the DIA community.”
Prior to joining Medidata, Hulihan served as senior vice president of regulatory consulting services at META Solutions Inc. and vice president of quality systems at EduQuest where he provided regulatory consulting, auditing and training services to the global pharmaceutical, biologics and medical device industries. Hulihan has held a variety of other senior management positions in the global pharmaceutical environment serving both pharmaceutical companies and CROs, and has been involved in research across the globe.
“Earl has shown an unmatched dedication to advancing the life sciences industry through his commitment to the DIA community throughout his career,” said Tarek Sherif, CEO of Medidata Solutions. “As one of the most sought after thought-leaders within Medidata and the industry at large, Earl continues to make vital contributions to his peers and colleagues that have helped drive significant developments and shape the future of the clinical world.”
The DIA Founders Service Award will be presented publicly during the DIA Annual Meeting at the Georgia World Congress Center (GWCC) in Atlanta, Georgia at 8:30 a.m. on June 18, 2007.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data—the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing life-enhancing treatments to market—on six continents and in more than 80 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com